Intervention Insights: Intervention Insights to Present at Boston Oncology Investor Conference 2019
Intervention Insights a healthtechnology company focused on resolving the complexities of precision medicine announced today that CEO Clynt Taylor will present its molecular testing platform Trapelo at the Boston Oncology Investor Conference on Friday Marc...
Read full article »
Intervention Insights provides a collaborative decision support platform for oncology care teams to deliver molecular diagnostics and targeted therapies.
Read more